Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Automated High-throughput Behavioral Measurement in Co-Housed Mice for Safer and More Effective Psychiatric Drug Development

Project description

Mice monitoring for psychiatric drug development

Drug development for psychiatric and neurological disorders relies on effective preclinical testing, but current rodent models can be resource-intensive and unreliable. With the growing need for ethical assessments of central nervous system (CNS) drugs, particularly in light of the opioid crisis, an automated system for simultaneous analysis of multiple subjects is crucial for improving efficiency and accuracy. The ERC-funded HOMECAGE project will develop a platform for continuously monitoring multiple subjects in their natural social environments. This system will meet industry standards and focus on addiction liability and sucrose preference, key assays related to depression and anxiety. It will enable precise observation of co-housed mice, serving as a ‘behavioural microscope’ to enhance the analysis of rodent behaviour.

Objective

Drug development for psychiatric and neurological disorders requires extensive preclinical testing for validation of safety and efficacy. Preclinical investigation of Central Nervous System (CNS) - acting drugs is primarily performed using traditional lab assays in rodent models. These experiments are typically based on manual analysis of isolated subjects, requiring huge investment in lab animals and technicians for brief measurements. These preclinical experiments are consequently subject to multiple sources of noise, and experience failures in prediction of clinical efficacy and safety. The need therefore exists for a scalable and automated preclinical experimental system for continuous parallel analysis of multiple co-housed subjects.

To address this industry need, we will develop the HOMECAGE—a first-of-its-kind, automated platform for continuous and parallel monitoring of the performance of multiple subjects in their native social environment. We will adapt HOMECAGE to industry standards, including its expansion to a broad range of preclinical experimental paradigms, and perform a comprehensive investigation of the IP landscape and appropriate business strategies for commercialization.

Increased vigilance in assaying the abuse liability of CNS-acting drugs has erupted following the opioid crisis, exemplifying the industry need for efficient, effective and ethical methodologies for preclinical assessment. Addiction liability and sucrose preference, most relevant to depression and anxiety, are the primary preclinical assays on which project HOMECAGE will focus.

The breakthrough automated system provided by HOMECAGE will facilitate continuous and accurate simultaneous monitoring of co-housed mice, acting as a revolutionary ‘behavioral microscope’ for radically improved throughput and increased resolution in the preclinical analysis of rodent behavior.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

THE HEBREW UNIVERSITY OF JERUSALEM
Net EU contribution
€ 150 000,00
Address
EDMOND J SAFRA CAMPUS GIVAT RAM
91904 Jerusalem
Israel
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)